179 related articles for article (PubMed ID: 21901297)
1. Switching from oxycodone to methadone in advanced cancer patients.
Mercadante S; Ferrera P; Villari P; Adile C; Casuccio A
Support Care Cancer; 2012 Jan; 20(1):191-4. PubMed ID: 21901297
[TBL] [Abstract][Full Text] [Related]
2. Frequency, indications, outcomes, and predictive factors of opioid switching in an acute palliative care unit.
Mercadante S; Ferrera P; Villari P; Casuccio A; Intravaia G; Mangione S
J Pain Symptom Manage; 2009 Apr; 37(4):632-41. PubMed ID: 19345298
[TBL] [Abstract][Full Text] [Related]
3. Rapid switching between transdermal fentanyl and methadone in cancer patients.
Mercadante S; Ferrera P; Villari P; Casuccio A
J Clin Oncol; 2005 Aug; 23(22):5229-34. PubMed ID: 16051965
[TBL] [Abstract][Full Text] [Related]
4. Serum concentrations of opioids when comparing two switching strategies to methadone for cancer pain.
Moksnes K; Kaasa S; Paulsen Ø; Rosland JH; Spigset O; Dale O
Eur J Clin Pharmacol; 2012 Aug; 68(8):1147-56. PubMed ID: 22374345
[TBL] [Abstract][Full Text] [Related]
5. How to switch from morphine or oxycodone to methadone in cancer patients? a randomised clinical phase II trial.
Moksnes K; Dale O; Rosland JH; Paulsen O; Klepstad P; Kaasa S
Eur J Cancer; 2011 Nov; 47(16):2463-70. PubMed ID: 21775131
[TBL] [Abstract][Full Text] [Related]
6. Switching methadone: a 10-year experience of 345 patients in an acute palliative care unit.
Mercadante S
Pain Med; 2012 Mar; 13(3):399-404. PubMed ID: 22360828
[TBL] [Abstract][Full Text] [Related]
7. Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain.
Benítez-Rosario MA; Feria M; Salinas-Martín A; Martínez-Castillo LP; Martín-Ortega JJ
Cancer; 2004 Dec; 101(12):2866-73. PubMed ID: 15529307
[TBL] [Abstract][Full Text] [Related]
8. Opioid plasma concentrations during a switch from transdermal fentanyl to methadone.
Mercadante S; Villari P; Ferrera P; Casuccio A; Gambaro V
J Palliat Med; 2007 Apr; 10(2):338-44. PubMed ID: 17472504
[TBL] [Abstract][Full Text] [Related]
9. The use of high doses of oxycodone in an acute palliative care unit.
Mercadante S; Ferrera P; David F; Casuccio A
Am J Hosp Palliat Care; 2011 Jun; 28(4):242-4. PubMed ID: 20826490
[TBL] [Abstract][Full Text] [Related]
10. Methadone in the treatment of pain and terminal delirum in advanced cancer patients.
Moryl N; Kogan M; Comfort C; Obbens E
Palliat Support Care; 2005 Dec; 3(4):311-7. PubMed ID: 17039986
[TBL] [Abstract][Full Text] [Related]
11. The use of fentanyl buccal tablets as breakthrough medication in patients receiving chronic methadone therapy: an open label preliminary study.
Mercadante S; Ferrera P; Arcuri E
Support Care Cancer; 2011 Mar; 19(3):435-8. PubMed ID: 20882391
[TBL] [Abstract][Full Text] [Related]
12. [Switching from oral oxycodone to oxycodone injection - an investigation into the dosage amount ratio].
Oda K; Kamiyama H; Goda Y
Gan To Kagaku Ryoho; 2015 Jan; 42(1):63-6. PubMed ID: 25596681
[TBL] [Abstract][Full Text] [Related]
13. Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: a prospective study.
Mercadante S; Casuccio A; Fulfaro F; Groff L; Boffi R; Villari P; Gebbia V; Ripamonti C
J Clin Oncol; 2001 Jun; 19(11):2898-904. PubMed ID: 11387363
[TBL] [Abstract][Full Text] [Related]
14. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
15. Methadone for cancer pain: what have we learned from clinical studies?
Soares LG
Am J Hosp Palliat Care; 2005; 22(3):223-7. PubMed ID: 15909785
[TBL] [Abstract][Full Text] [Related]
16. Factors predicting requirement of high-dose transdermal fentanyl in opioid switching from oral morphine or oxycodone in patients with cancer pain.
Kanbayashi Y; Hosokawa T; Okamoto K; Fujimoto S; Konishi H; Otsuji E; Yoshikawa T; Takagi T; Miki T; Taniwaki M
Clin J Pain; 2011 Oct; 27(8):664-7. PubMed ID: 21471811
[TBL] [Abstract][Full Text] [Related]
17. Switching to Intravenous Methadone in Advanced Cancer Patients: A Retrospective Analysis.
Mercadante S; Cascio AL; Casuccio A
J Pain Symptom Manage; 2023 Oct; 66(4):287-292. PubMed ID: 37236430
[TBL] [Abstract][Full Text] [Related]
18. Tapentadol in Cancer Patients with Neuropathic Pain: A Comparison of Methadone, Oxycodone, Fentanyl, and Hydromorphone.
Takemura M; Niki K; Okamoto Y; Matsuda Y; Omae T; Takagi T; Ueda M
Biol Pharm Bull; 2021; 44(9):1286-1293. PubMed ID: 34471056
[TBL] [Abstract][Full Text] [Related]
19. Oxycodone controlled-release as first-choice therapy for moderate-to-severe cancer pain in Italian patients: results of an open-label, multicentre, observational study.
Silvestri B; Bandieri E; Del Prete S; Ianniello GP; Micheletto G; Dambrosio M; Sabbatini G; Endrizzi L; Marra A; Aitini E; Calorio A; Garetto F; Nastasi G; Piantedosi F; Sidoti V; Spanu P
Clin Drug Investig; 2008; 28(7):399-407. PubMed ID: 18544000
[TBL] [Abstract][Full Text] [Related]
20. Morphine-methadone opioid rotation in cancer patients: analysis of dose ratio predicting factors.
Benítez-Rosario MA; Salinas-Martín A; Aguirre-Jaime A; Pérez-Méndez L; Feria M
J Pain Symptom Manage; 2009 Jun; 37(6):1061-8. PubMed ID: 19171458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]